Find the Physician Practices Your Sales Team Should Target Next.
NYSOM Copilot monitors physician-market growth, ranks commercial opportunities, explains why accounts matter now, and tells your team what to do next.
Built initially for orthopedic medical device commercial teams.
Your AI Commercial Intelligence Analyst
Your AI Commercial Intelligence Analyst
Ask questions in plain language. NYSOM Copilot analyzes your market’s signals and returns ranked accounts, evidence-backed recommendations, territory insights, and account-specific outreach.
Try asking
Based on this month’s expansion signals, here are your top 3 priorities by commercial opportunity score:
Added 4 surgeons + new ASC in 60 days
Opened 2nd location; hiring 3 providers
Referral network expanded 18% this quarter
Want me to draft outreach for all three?
Illustrative preview · responses shown are examples
Every week, know exactly where your sales team should focus
NYSOM continuously evaluates your market and identifies the 25 physician practices most aligned with your company’s ICP, territory, and current commercial signals.
Example Orthopedic Specialists
Atlanta, GA
Why now
- +3 orthopedic surgeons added
- +New location signal
- +Practice growth detected
Action
Contact this week
Example Bone & Joint Group
Savannah, GA
Why now
- +New ambulatory surgery center
- +Referral network expanding
Action
Prioritize for outreach
Example Sports Medicine Institute
Augusta, GA
Why now
- +2 sports-medicine hires
- +Second clinic opening
Action
Warm intro recommended
Example Spine & Orthopedics
Columbus, GA
Why now
- +Provider joined from larger group
- +Case volume trending up
Action
Add to this month’s plan
Example Regional Orthopedic Partners
Macon, GA
Why now
- +Practice acquisition completed
- +New payer contracts
Action
Monitor + qualify
Three questions. One commercial intelligence system.
Who should we target?
NYSOM ranks physician practices based on your ICP, territory, and commercial opportunity.
Why now?
NYSOM identifies the market changes and evidence behind each opportunity.
What should we do next?
NYSOM recommends the next commercial action and helps your team prepare outreach.
From market change to sales action
NYSOM turns healthcare market intelligence into a prioritized commercial workflow.
The NYSOM Evidence Standard
Enterprise buyers do not act on unexplained scores. Every element of a NYSOM opportunity is labeled by how it was established — so you always know what is a verified fact, what is a derived signal, and what is an AI recommendation before you act.
Directly supported by an identified, authoritative source — with provenance you can trace.
A structured inference or commercial interpretation derived from evidence — clearly marked as derived, not reported.
A recommended commercial action generated from the available evidence, with reasoning and a confidence level.
Know the account before your rep calls
Open any opportunity and NYSOM shows the full picture — opportunity score, why now, provider growth, locations, evidence, the commercial interpretation, and the recommended next action.
Summit Orthopedic & Sports Medicine (Illustrative)
Orthopedics · Southeast metro · Independent multi-site group
Opportunity Score
Confidence: High (0.92)
Evidence & Signals
- Verified Fact
Registered as an active multi-provider orthopedic group in the target metro (CMS NPPES public registry).
- Verified Fact
Surgeon census recorded as expanding from 8 to 13 enumerated clinicians across the last two registry updates.
- Verified Fact
A newly registered ambulatory surgery center location tied to the group appears within the target territory.
- Verified Fact
Two of the newly added surgeons carry sports-medicine and joint-reconstruction taxonomies.
- Derived Signal
Growth pattern is consistent with capacity expansion — a window when implants, instrumentation, and platform decisions are typically evaluated.
- Derived Signal
Sub-specialty mix suggests near-term demand for joint-reconstruction and sports-medicine product lines.
Why This Account Matters
Derived SignalRapid surgeon and ASC growth signals capacity expansion — the window when orthopedic equipment, implant, and platform decisions are most likely to be evaluated. Reaching this account before it standardizes on a competitor is the difference between a default vendor and a displacement fight.
Likely Buyer
AI RecommendationPractice Administrator or Managing Partner — the operational owner of procurement and expansion decisions in an independent orthopedic group, with the ASC medical director as a likely clinical influencer.
Recommended Message
AI RecommendationLead with the expansion angle: acknowledge their recent surgeon and ASC growth, and frame the offer around supporting added surgical capacity without adding operational drag or supply-chain risk.
Next Best Action
AI RecommendationSend the expansion-focused intro email in the deployment sequence, then follow with a LinkedIn touch to the administrator within three business days and flag the ASC medical director for a clinical follow-up.
See what NYSOM finds in your market
Tell us what you sell and where your team sells. We’ll prepare a complimentary commercial intelligence snapshot showing a small number of physician-practice opportunities NYSOM believes deserve attention.
Your market snapshot is prepared and reviewed before delivery.
Get My Free Market SnapshotYour free market snapshot
5 selected physician-practice opportunities. For each:
- Account
- Opportunity signal
- Why now
- Supporting evidence
- Commercial implication
- Recommended next action
The commercial intelligence layer between healthcare data and sales action
Other tools stop at the data. NYSOM turns it into the decision.
Traditional healthcare data
Answers
Who exists?
Static reports
Answers
What happened?
Generic AI
Answers
Whatever information you provide it.
NYSOM
Answers
- Who should we target?
- Why now?
- What evidence supports it?
- What should we do next?
NYSOM 90-Day Commercial Intelligence Pilot
- NYSOM Copilot
- Personalized ICP configuration
- Ranked physician-practice opportunities
- My Next 25 weekly priorities
- Opportunity Scores
- Why Now analysis
- Evidence-backed recommendations
- Account Intelligence Profiles
- Territory intelligence
- Outreach generation
- Weekly intelligence updates
- Monthly Executive Intelligence Brief
- Monthly Commercial Intelligence Strategy Review
A paid engagement to prove NYSOM on one real market. Production plans scale from $3,500/month once it works — see full pricing.
Start with a complimentary market snapshot for your specialty and region. If the intelligence is a fit, we’ll walk your team through a live strategy demo and scope the 90-day engagement together.
Get My Free Market Snapshot Apply for a PilotNo self-service checkout. Engagements begin after a qualification conversation.
High-touch implementation, not consulting
Early NYSOM customers receive direct founder involvement during onboarding, ICP configuration, intelligence review, and monthly strategy sessions — so the platform is tuned to how your team actually sells.
One qualified account changes the math
NYSOM annual cost
$42,000
What is one qualified orthopedic account worth to your company?
Model your own numbersIllustrative only. NYSOM does not guarantee sales outcomes.
Free market-level intelligence
Start with the 2026 Southeast Orthopedic Growth Intelligence Report. Market-level intelligence, free to read — the paid platform adds account-level prioritization, evidence, and recommendations.
See what NYSOM finds in your market
Tell us what you sell and where your team sells. Your snapshot is prepared and reviewed before delivery.